Navigation Links
Gene Governs Response to Leukemia Chemotherapy
Date:1/7/2009

h outcome," Downing said.

Downing and his colleagues conducted gene analyses of 221 children with high-risk ALL who were being treated for the disease as part of another study.

Deletions or changes in the IKAROS gene (of which there were several) that were found in slightly more than one-quarter of the patients were associated with a worse outcome. The findings were validated in a second group of 258 children.

IKAROS produces the IKAROS protein, which is involved in regulating other genes.

"The mutations of IKAROS were shown to be independent prognostic indicators, they had high value to identify patients at high risk of relapse over and above known risk factors," Downing said. "Identification of these lesions at the time of diagnosis would provide new information to better identify those patients."

It's unknown how the gene works at this point, but Downing speculated that it has to do with the gene's role in regulating the formation of lymphocyte cells.

Diagnostic tests need to be developed before the study results -- which also need to be replicated -- can be of benefit to patients, the researchers said.

There's another potential benefit down the road: new information to help find new targets for drugs.

More information

Visit the U.S. National Cancer Institute for more on ALL in children.



SOURCES: James R. Downing, M.D., scientific director, St. Jude Children's Research Hospital, Memphis, Tenn.; Arthur Frankel, M.D., professor, medicine, Texas A&M Health Science Center College of Medicine, and director, Cancer Center, Cancer Research Institute and Division of Hematology/Oncology, Scott & White Hospital, Jan. 7, 2009, New England Journal of Medicine, online


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Specific Brain Region Governs Problem-Solving Skills
2. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
3. Study identifies key player in the bodys immune response to chronic stress
4. Retired NYPD Lieutenants William E. Keegan, Jr., Owen McCaffery and John Moran and Tom Thees, a former COO in the financial industry, announce today the formation of H.E.A.R.T (Healing Emergency Aid Response Team) 911.
5. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
6. Merck & Co., Inc. Response to Todays New York Medicaid Suit
7. Maternal depression and controlling behavior associated with increased stress response in infants
8. Family history of alcoholism affects response to drug used to treat heavy drinking
9. Molecular fingerprint of breast-cancer drug resistance can predict response to treatment
10. Breast cancer susceptibility gene predicts outcome and response to treatment in lung cancer
11. PET scans can accurately detect a breast tumors response to chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 3Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 4Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 5Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 3Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 4Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 5Health News:VitaminSpice Signs Agreement With Former CEO of Wal-Mart Stores Division for US Distribution 2Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 2Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 3Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 4Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 5Health News:New approach to sickle-cell disease shows promise in mice 2
Breaking Medicine Technology:VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3Hair Fairies Kicks Off the Holiday Season With an All Natural Head Lice Product Giveaway 62116 1Hair Fairies Kicks Off the Holiday Season With an All Natural Head Lice Product Giveaway 62116 2Hair Fairies Kicks Off the Holiday Season With an All Natural Head Lice Product Giveaway 62116 3Par Pharmaceutical Announces Results of Its Modified Dutch Auction Tender Offer 62113 1Par Pharmaceutical Announces Results of Its Modified Dutch Auction Tender Offer 62113 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 1Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 14976 9